Cozzarini C - Search Results

1

Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.

Fossati N, Robesti D, Karnes RJ, Soligo M, Boorjian SA, Bossi A, Coraggio G, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Scarcella S, Bartkowiak D, Böhmer D, Shariat S, Goldner G, Battaglia A, Joniau S, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A. Fossati N, et al. Among authors: cozzarini c. Eur Urol. 2019 Oct;76(4):443-449. doi: 10.1016/j.eururo.2019.02.004. Epub 2019 Feb 22. Eur Urol. 2019. PMID: 30799187

2

Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.

Cozzarini C, Bolognesi A, Ceresoli GL, Fiorino C, Rossa A, Bertini R, Colombo R, Da Pozzo L, Montorsi F, Roscigno M, Calandrino R, Rigatti P, Villa E. Cozzarini C, et al. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):674-83. doi: 10.1016/j.ijrobp.2003.12.001. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183470

3

A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy.

Roscigno M, Cozzarini C, Scattoni V, Bertini R, Da Pozzo L, Pasta A, Montorsi F, Bolognesi A, Fiorino C, Colombo R, Fazio F, Rigatti P. Roscigno M, et al. Among authors: cozzarini c. Radiother Oncol. 2007 Jan;82(1):30-7. doi: 10.1016/j.radonc.2006.11.017. Epub 2006 Dec 21. Radiother Oncol. 2007. PMID: 17187884

4

Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer.

Cozzarini C, Fiorino C, Di Muzio N, Alongi F, Broggi S, Cattaneo M, Montorsi F, Rigatti P, Calandrino R, Fazio F. Cozzarini C, et al. Radiother Oncol. 2007 Aug;84(2):164-70. doi: 10.1016/j.radonc.2007.07.013. Epub 2007 Aug 13. Radiother Oncol. 2007. PMID: 17706308

5

Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.

Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, Briganti A, Gallina A, Capitanio U, Colombo R, Giorgio G, Montorsi F, Rigatti P. Roscigno M, et al. Among authors: cozzarini c. Eur Urol. 2008 Apr;53(4):794-802. doi: 10.1016/j.eururo.2008.01.008. Epub 2008 Jan 15. Eur Urol. 2008. PMID: 18207313

6

Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review.

Motta M, Alongi F, Bolognesi A, Cozzarini C, Di Muzio N, Fazio F. Motta M, et al. Among authors: cozzarini c. Neurologist. 2008 Mar;14(2):120-4. doi: 10.1097/NRL.0b013e31815b97ec. Neurologist. 2008. PMID: 18332841 Review.

7

Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy.

Fiorino C, Di Muzio N, Broggi S, Cozzarini C, Maggiulli E, Alongi F, Valdagni R, Fazio F, Calandrino R. Fiorino C, et al. Among authors: cozzarini c. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):611-7. doi: 10.1016/j.ijrobp.2008.01.048. Epub 2008 Apr 18. Int J Radiat Oncol Biol Phys. 2008. PMID: 18374511

8

Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a Phase I-II study.

Cozzarini C, Fiorino C, Di Muzio N, Valdagni R, Salonia A, Alongi F, Broggi S, Guazzoni G, Montorsi F, Rigatti P, Calandrino R, Fazio F. Cozzarini C, et al. Radiother Oncol. 2008 Jul;88(1):26-33. doi: 10.1016/j.radonc.2008.03.021. Epub 2008 Apr 30. Radiother Oncol. 2008. PMID: 18455253 Clinical Trial.

9

Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues.

Fiorino C, Alongi F, Broggi S, Cattaneo GM, Cozzarini C, Di Muzio N, Maggiulli E, Mangili P, Perna L, Valdagni R, Fazio F, Calandrino R. Fiorino C, et al. Among authors: cozzarini c. Acta Oncol. 2008;47(7):1309-16. doi: 10.1080/02841860802266755. Acta Oncol. 2008. PMID: 18686050 Free article.

10

Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML. Briganti A, et al. Among authors: cozzarini c. Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1. Eur Urol. 2009. PMID: 18838212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters